Tag: myocardial infarction
Troponin Elevation in Non-cardiac Critical Illness
This article is about how to approach ischemia evaluation for the "non-cardiac" critically ill patient (someone admitted for a problem such as sepsis, stroke, or DKA). This is tough. We want to be thorough enough not to miss... read more
Management of Cardiogenic Shock Complicating Myocardial Infarction – 2019 Update
In general, randomized clinical trials in CS are difficult to perform and only three randomized trials adequately powered to detect differences in clinical outcomes achieved completion of the required number of patients. Based... read more
Multipotent Fetal-derived Cdx2 Cells From Placenta Regenerate the Heart
Researchers at the Icahn School of Medicine at Mount Sinai have demonstrated that stem cells derived from the placenta known as Cdx2 cells can regenerate healthy heart cells after heart attacks in animal models. The extremely... read more
Early or Delayed Cardioversion in Recent-Onset Atrial Fibrillation
In patients presenting to the emergency department with recent-onset, symptomatic atrial fibrillation, a wait-and-see approach was noninferior to early cardioversion in achieving a return to sinus rhythm at 4 weeks. The presence... read more
Hoopla Aside, hs-cTnI is Not Catching Missed Mis
We have been searching for a tool to identify myocardial infarction patients who are truly safe for discharge ever since Pope, et al., found that we were discharging two percent of patients with MIs from the emergency department.... read more
High-Sensitivity Troponins and Outcomes After Myocardial Infarction
An excellent report from Kai Eggers et al in Sweden on impact of introducing high-sensitivity cardiac troponins in 87,879 patients with myocardial infarction. In a nationwide cohort study on patients with a first MI, the... read more
Nicorandil Protects Older Patients from Myocardial Injury After PCI
Intravenous nicorandil cut the risk of periprocedural myocardial injury (pMI) after percutaneous coronary intervention (PCI) by 49 percent among patients 65 and older, according to a substudy of a randomized trial published... read more
Understanding How to Improve Quality and Value for Patients With AMI
Although the United States lags behind comparable nations in many health measures, mortality following acute myocardial infarction (AMI) is lower in the United States than in many other developed countries, including Finland,... read more
Accuracy of Medical Claims for Identifying Cardiovascular and Bleeding Events After Myocardial Infarction
In this secondary analysis of a clinical trial of 12 365 patients with acute myocardial infarction, the cumulative 1-year event rates for myocardial infarction, stroke, and bleeding were lower when medical claims were used... read more
Pain Sensitivity Plays a Role in Unrecognized Myocardial Infarction
People who experience unrecognized or silent myocardial infarction may have reduced pain sensitivity compared with those whose Myocardial Infarction is noticed, according to the results of a study recently published online... read more
